Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $115,488.72 -0.03%
Ethereum $4,141.92 -1.80%
BNB $1,144.54 -0.34%
Optimism $0.46 -2.08%
Arbitrum $0.33 -2.96%
Solana $200.57 -1.27%
Polygon $0.22 +2.77%
Cosmos $3.19 -1.38%
Avalanche $20.13 -2.78%

Bitcoin $115,488.72 -0.03%
Ethereum $4,141.92 -1.80%
BNB $1,144.54 -0.34%
Optimism $0.46 -2.08%
Arbitrum $0.33 -2.96%
Solana $200.57 -1.27%
Polygon $0.22 +2.77%
Cosmos $3.19 -1.38%
Avalanche $20.13 -2.78%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B